WelcomeUser Guide
ToSPrivacyCanary
DonateBugsLicense

©2025 Poal.co

521

One, Two, Three, Dead.

https://apnews.com/article/business-health-coronavirus-pandemic-c7c6de905cd614d66cdf727dda661c5a

"Those agencies, though, are awaiting critical data [like how many purebloods there still are?] before signing off on the third doses, with Moderna’s vaccine increasingly seen as unlikely to make the Sept. 20 milestone."

"According to one official, Moderna produced inadequate data for the FDA and CDC to recommend the third dose of its vaccine and FDA has requested additional data that is likely to delay those boosters into October. Pfizer, which is further along in the review process, in part because of data collected from the vaccine’s use in Israel, is still expected to be approved for a third dose for all by Sept. 20. A key FDA panel is to review Pfizer’s data on boosters on Sept. 17."

Cohencidentally, October is when many mandates take place, also when the booster may be delayed until. Convenient.

One, Two, Three, Dead. https://apnews.com/article/business-health-coronavirus-pandemic-c7c6de905cd614d66cdf727dda661c5a "Those agencies, though, are awaiting critical data [*like how many purebloods there still are?*] before signing off on the third doses, with Moderna’s vaccine increasingly seen as unlikely to make the Sept. 20 milestone." "According to one official, Moderna produced inadequate data for the FDA and CDC to recommend the third dose of its vaccine and FDA has requested additional data that is **likely to delay those boosters into October.** Pfizer, which is further along in the review process, in part because of data collected from the vaccine’s use in Israel, is still expected to be approved for a third dose for all by Sept. 20. A key FDA panel is to review Pfizer’s data on boosters on Sept. 17." Cohencidentally, October is when many mandates take place, also when the booster may be delayed until. Convenient.

(post is archived)

[–] 1 pt

50% are unvaxxed. and are unwilling to get it . and will never get it.

Yep. They need to bridge the gap between unjabbed and double jabbed first. Otherwise the results will be glaringly obvious.

The hilarity is they can barely contain the frontliners who are rolling up their sleeves for number 3 already.

[–] 0 pt

Or....ya know, they are just holding off to generate faux credibility.

[–] 0 pt

possible...but how's a '3rd dose' of jew juice, any different from what they took in #1 & #2, that's already approved? Just another safe & effective dose....why do they pretend to need to approve these boosters? Like boosters weren't part of the plan all along. And you believe that they need just enoug time to approve the booster, that they need to outlast purebloods.

[–] 1 pt

That's it. To make the skeptical minded (but ultimately devoid of critical thinking) people, comply.

To make it seem as though there are legitimate studies and "push back" against the vaccines.

To appear as authentic. That's all this is. Theater.

[–] 0 pt (edited )

The FDA just had their review of the booster and they don't recommended it for people below 65.

The Biden admin would have a weird time getting around the FDA so quickly.

Instead of booster, since they are obviously failing in Israel, I suspect that they will have yearly Flu-Covid shot that target the new strain. I think there would be less pushback against that since it doesn't look like the shot is shit, it looks like business as usual (flu wise).

[–] 0 pt
[–] 0 pt

When does the FDA recommend drugs?

Is that a thing?

[–] 0 pt

At least in this instance they did a risk-benefit analysis.